2023 Innovation: Infinite Possibilities Translational Science Summit and Andover Bio's 5th Anniversary Celebration

On May 12, 2023, Andu Biosciences will host the “Summit on Translational Science” alongside its fifth-anniversary celebrations. The summit will feature six thematic presentations and one panel discussion centered on translational science. Leading experts and scholars from diverse fields within the biopharmaceutical industry will convene in Hangzhou to engage in rigorous discourse and in-depth exploration of topics such as the development and application of novel drug technologies and clinical translation. The event aims to accelerate the clinical adoption of new technologies, thereby benefiting patients at the earliest possible stage.

13 Leading Industry Experts Share Their Outlook on Industry Trends.

Bringing together top experts from the biopharmaceutical industry, including Andu Bio, Fudan University, Immune Ark, Baikai Pharma, ImmuOnco, the Cancer Hospital of the Chinese Academy of Medical Sciences, CytoSolve, Yiming Oncology, Rannuo Bio, HuaaoTai Bio, LinkMed Pharmaceuticals, and Huod Bio, to jointly forecast industry trends.

Six Thematic Reports: Discussing New Drug Development.

“Challenges and Opportunities in Biopharmaceutical Innovation in China,” “Challenges and Opportunities in the Development of Antibody Drugs for Tumor Immunotherapy,” “Innovation and R&D of ADC Drugs from the Perspective of Translational Science,” “Tumor Immunotherapy in the Era of Antibody 2.0: From ADCs to ACCs,” “Current Status of Clinical Needs in Oncology in China and New Drug Development Guided by Clinical Value,” and “Considerations and Case Sharing on Non-Clinical Evaluation of Gene Therapy Products.”

One roundtable discussion exploring the development and application of translational science.

Conduct a roundtable discussion on “The Application of Translational Science in New Drug Development,” featuring the exchange of perspectives and in-depth deliberation.

As a globally leading next-generation CRO in translational and clinical development, Andu Bio serves as the preferred partner for successful innovative drug R&D. We provide end-to-end services compliant with international standards across China, Europe, and the United States, covering translational science, quantitative pharmacology, bioanalysis and biomarkers, regulatory submissions, and clinical development. Our offerings include clinical development strategy and execution from preclinical stages through to market launch, scientifically optimizing dose selection, target selection, and patient selection. By integrating global quality execution standards, we enhance the success rate of new drug development. Our client base ranges from top-tier startup biotech companies to multinational pharmaceutical enterprises. To date, the Andu team has successfully completed over 210 marketing authorization submissions (NDA, BLA, MAA) in China, the United States, Europe, and Japan for domestic and international clients.

VCBeat Online Live Streaming Channel

Andu Bio Live Streaming Channel